Karolinska Financial Statements From 2010 to 2024
| KDEV Stock | SEK 1.06 0.03 2.91% |
Check Karolinska Development financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Karolinska Development's main balance sheet or income statement drivers, such as , as well as many indicators such as . Karolinska financial statements analysis is a perfect complement when working with Karolinska Development Valuation or Volatility modules.
Karolinska |
Karolinska Development AB Company Return On Asset Analysis
Karolinska Development's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Karolinska Development Return On Asset | -0.0168 |
Most of Karolinska Development's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Karolinska Development AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Karolinska Development AB has a Return On Asset of -0.0168. This is 99.81% lower than that of the Pharmaceuticals sector and 99.93% lower than that of the Health Care industry. The return on asset for all Sweden stocks is 88.0% lower than that of the firm.
Karolinska Development Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Karolinska Development's current stock value. Our valuation model uses many indicators to compare Karolinska Development value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Karolinska Development competition to find correlations between indicators driving Karolinska Development's intrinsic value. More Info.Karolinska Development AB is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Karolinska Development's earnings, one of the primary drivers of an investment's value.About Karolinska Development Financial Statements
Karolinska Development shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Karolinska Development investors may analyze each financial statement separately, they are all interrelated. The changes in Karolinska Development's assets and liabilities, for example, are also reflected in the revenues and expenses on on Karolinska Development's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Karolinska Development AB is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. Karolinska Development AB was founded in 2003 and is headquartered in Stockholm, Sweden. Karolinska Development operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 7 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Karolinska Stock Analysis
When running Karolinska Development's price analysis, check to measure Karolinska Development's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Karolinska Development is operating at the current time. Most of Karolinska Development's value examination focuses on studying past and present price action to predict the probability of Karolinska Development's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Karolinska Development's price. Additionally, you may evaluate how the addition of Karolinska Development to your portfolios can decrease your overall portfolio volatility.